EN
The Link Between COVID-19 and Executive Functions in the Geriatric Population: A Descriptive Cross-Sectional Study
Abstract
Background: Geriatric population is known to be at a greater risk for the Coronavirus-19 (COVID-19). Previous literature provided evidence for the association between viral infections and cognitive decline. The aim of this study was to evaluate executive functions in older adults who were infected by COVID-19.
Methods: A total of 47 participants with healthy cognition over the age of 65 (M:75.4±5.91, minimum-maximum:65-85) were enrolled in the study. The sample was selected from older adults residing in a nursing home in Istanbul. Based on their history of COVID-19 infection, the sample was divided into two groups as COVID-P (22 participants who got Covid-19 in the last six months) and COVID-N (25 participants who did not get Covid-19) which did not significantly differ in terms of age and education. A mini mental state examination was applied to verify the mental status of participants. Trail Making Test (TMT) and Clock Drawing test (CDT) were used to assess executive functions.
Results: The analyses showed that COVID-P group displayed significantly lower performance in the completion of both forms of TMT as compared to COVID-N group (p< .05 for both TMT-A and TMT-B). However, groups did not significantly differ in their CDT performance (p> .05).
Conclusion: Based on the findings, it is possible to conclude that COVID-19 can negatively affect the executive functions in the old age population.
Keywords
References
- Almeria M, Cejudo JC, Sotoca J, et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain, behavior, & immunity-health. 2020;9:100163.
- Alonso-Lana S, Marquié M, Ruiz A, et al. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Frontiers in aging neuroscience. 2020;369.
- Liu YH, Chen Y, Wang QH, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA neurology. 2022; 79(5), 509-517.
- Tondo G, Sarasso B, Serra P, et al. The Impact of the COVID-19 Pandemic on the Cognition of People with Dementia. International Journal of Environmental Research and Public Health. 2021;18(8):4285.
- Arica-Polat BS, Gündoğdu AA, Cinar N, et al. Evaluation of cognitive deficits in patients infected with COVID-19. European Review for Medical and Pharmacological Sciences. 2022;26(2):678-685.
- Itzhaki RF and Wozniak MA. Viral infection and cognitive decline. Journal of the American Geriatrics Society. 2007;55:131–131. https://doi.org/10.1111/j.1532-5415.2006.01001.x
- Sochocka M, Zwolińska K and Leszek J. The infectious etiology of Alzheimer’s disease. Current Neuropharmacology. 2017;15:996–1009. https://doi.org/10.2174/1570159x15666170313122937
- Muñoz LS, Garcia MA, Gordon-Lipkin E, et al. Emerging viral infections and their impact on the global burden of neurological disease. Seminars in Neurology. 2018;38:163–175. https://doi.org/10.1055/s-0038-1647247
Details
Primary Language
English
Subjects
Geriatrics and Gerontology , Neurosciences
Journal Section
Research Article
Publication Date
March 17, 2023
Submission Date
January 2, 2023
Acceptance Date
February 19, 2023
Published in Issue
Year 1970 Volume: 14 Number: 2